Atlas Trials

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

Clinical trial NCT06125262 · UNKNOWN

Trial details

NCT number
NCT06125262
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Esophageal Squamous Cell CarcinomaImmunotherapyChemotherapy
Start date
2022-11-01
Primary completion
2024-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.